162 related articles for article (PubMed ID: 28820713)
21. Fake artesunate in southeast Asia.
Newton P; Proux S; Green M; Smithuis F; Rozendaal J; Prakongpan S; Chotivanich K; Mayxay M; Looareesuwan S; Farrar J; Nosten F; White NJ
Lancet; 2001 Jun; 357(9272):1948-50. PubMed ID: 11425421
[TBL] [Abstract][Full Text] [Related]
22. Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar.
Lohy Das JP; Kyaw MP; Nyunt MH; Chit K; Aye KH; Aye MM; Karlsson MO; Bergstrand M; Tarning J
Malar J; 2018 Mar; 17(1):126. PubMed ID: 29566683
[TBL] [Abstract][Full Text] [Related]
23. Artemisinin drugs: novel antimalarial agents.
Price RN
Expert Opin Investig Drugs; 2000 Aug; 9(8):1815-27. PubMed ID: 11060779
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of substandard and falsified artemisinin-based combination antimalarial medicines on Bioko Island, Equatorial Guinea.
Kaur H; Allan EL; Mamadu I; Hall Z; Green MD; Swamidos I; Dwivedi P; Culzoni MJ; Fernandez FM; Garcia G; Hergott D; Monti F
BMJ Glob Health; 2017; 2(4):e000409. PubMed ID: 29082025
[TBL] [Abstract][Full Text] [Related]
25. Development of an agent-based model to assess the impact of substandard and falsified anti-malarials: Uganda case study.
Ozawa S; Evans DR; Higgins CR; Laing SK; Awor P
Malar J; 2019 Jan; 18(1):5. PubMed ID: 30626380
[TBL] [Abstract][Full Text] [Related]
26. Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.
Haynes RK; Cheu KW; N'Da D; Coghi P; Monti D
Infect Disord Drug Targets; 2013 Aug; 13(4):217-77. PubMed ID: 24304352
[TBL] [Abstract][Full Text] [Related]
27. Who continues to stock oral artemisinin monotherapy? Results of a provider survey in Myanmar.
Thein ST; Sudhinaraset M; Khin HS; McFarland W; Aung T
Malar J; 2016 Jun; 15():334. PubMed ID: 27333781
[TBL] [Abstract][Full Text] [Related]
28. Fake anti-malarials: start with the facts.
Kaur H; Clarke S; Lalani M; Phanouvong S; Guérin P; McLoughlin A; Wilson BK; Deats M; Plançon A; Hopkins H; Miranda D; Schellenberg D
Malar J; 2016 Feb; 15():86. PubMed ID: 26873700
[TBL] [Abstract][Full Text] [Related]
29. A New Handheld Device for the Detection of Falsified Medicines: Demonstration on Falsified Artemisinin-Based Therapies from the Field.
Wilson BK; Kaur H; Allan EL; Lozama A; Bell D
Am J Trop Med Hyg; 2017 May; 96(5):1117-1123. PubMed ID: 28219992
[TBL] [Abstract][Full Text] [Related]
30. Rapid quantification of artemisinin derivatives in antimalarial drugs with dipstick immunoassays.
Qian J; He Q; Liu L; Wang M; Wang B; Cui L
J Pharm Biomed Anal; 2020 Nov; 191():113605. PubMed ID: 32961520
[TBL] [Abstract][Full Text] [Related]
31. Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives.
Price R; van Vugt M; Phaipun L; Luxemburger C; Simpson J; McGready R; ter Kuile F; Kham A; Chongsuphajaisiddhi T; White NJ; Nosten F
Am J Trop Med Hyg; 1999 Apr; 60(4):547-55. PubMed ID: 10348227
[TBL] [Abstract][Full Text] [Related]
32. Global scenario of counterfeit antimalarials: A potential threat.
Arora T; Sharma S
J Vector Borne Dis; 2019; 56(4):288-294. PubMed ID: 33269727
[TBL] [Abstract][Full Text] [Related]
33. Rapid and specific drug quality testing assay for artemisinin and its derivatives using a luminescent reaction and novel microfluidic technology.
Ho NT; Desai D; Zaman MH
Am J Trop Med Hyg; 2015 Jun; 92(6 Suppl):24-30. PubMed ID: 25897061
[TBL] [Abstract][Full Text] [Related]
34. Collaborative health and enforcement operations on the quality of antimalarials and antibiotics in southeast Asia.
Yong YL; Plançon A; Lau YH; Hostetler DM; Fernández FM; Green MD; Sounvoravong S; Nara S; Boravann M; Dumrong T; Bangsawan N; Low MY; Lim CC; Ai RLC; Newton PN
Am J Trop Med Hyg; 2015 Jun; 92(6 Suppl):105-112. PubMed ID: 25897069
[TBL] [Abstract][Full Text] [Related]
35. Availability and quality of anti-malarials among private sector outlets in Myanmar in 2012: results from a large, community-based, cross-sectional survey before a large-scale intervention.
Khin HS; Chen I; White C; Sudhinaraset M; McFarland W; Littrell M; Montagu D; Aung T
Malar J; 2015 Jul; 14():269. PubMed ID: 26169498
[TBL] [Abstract][Full Text] [Related]
36. Authentication of artemether, artesunate and dihydroartemisinin antimalarial tablets using a simple colorimetric method.
Green MD; Mount DL; Wirtz RA
Trop Med Int Health; 2001 Dec; 6(12):980-2. PubMed ID: 11737833
[TBL] [Abstract][Full Text] [Related]
37. Plasmodium falciparum-based bioassay for measurement of artemisinin derivatives in plasma or serum.
Teja-Isavadharm P; Peggins JO; Brewer TG; White NJ; Webster HK; Kyle DE
Antimicrob Agents Chemother; 2004 Mar; 48(3):954-60. PubMed ID: 14982789
[TBL] [Abstract][Full Text] [Related]
38. Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria.
Price RN; Nosten F; Luxemburger C; Kham A; Brockman A; Chongsuphajaisiddhi T; White NJ
Trans R Soc Trop Med Hyg; 1995; 89(5):523-7. PubMed ID: 8560531
[TBL] [Abstract][Full Text] [Related]
39. A nationwide survey of the quality of antimalarials in retail outlets in Tanzania.
Kaur H; Goodman C; Thompson E; Thompson KA; Masanja I; Kachur SP; Abdulla S
PLoS One; 2008; 3(10):e3403. PubMed ID: 18923672
[TBL] [Abstract][Full Text] [Related]
40. In vitro sensitivity of antimalarial drugs and correlation with clinico-parasitological response following treatment with a 3-day artesunate-mefloquine combination in patients with falciparum malaria along the Thai-Myanmar border.
Muhamad P; Thiengsusuk A; Phompradit P; Na-Bangchang K
Acta Trop; 2017 Feb; 166():257-261. PubMed ID: 27866919
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
